US7469641051
US7469641051
Q32 Bio Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 53.737.000 | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 36.835.000 | 66.102.000 | 44.3% | |
| Operating Income | 16.902.000 | -66.102.000 | 125.6% |
| Pretax Income | 29.821.000 | -46.087.000 | 164.7% |
| Net Income Common Stockholders | 29.821.000 | -47.733.000 | 162.5% |
| -- | -- | -- | |
| -- | -- | -- |